4th Quarter - Report

SANOFI US SERVICES INC. for SANOFI US SERVICES INC

Firm
Client
Income
—
Expenses
$790,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to the repeal of Non-Interference in Part D.

Foreign entity interest: Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
JUAN MACHADO —

Contacted: Natl Security Council (NSC); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Office of Management & Budget (OMB)

Taxation/Internal Revenue Code TAX

Issues related to H.R.4993 "Vaccine Access Improvement Act of 2018"; and issues related to Orphan Drug Tax Credit

Foreign entity interest: Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
MARYANNE DOLBEARE DUNLAP —
KATIE OPPENHEIM —
AMY L REDL —
ELIZABETH STOWER —

Contacted: Natl Security Council (NSC); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4993 (115th)

Copyright/Patent/Trademark CPT

Issues related to Compulsory Licensing.

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
MARYANNE DOLBEARE DUNLAP —
JUAN MACHADO —
ELIZABETH STOWER —

Contacted: Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); SENATE; Natl Security Council (NSC); HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues related to S.2315 "Over-the-Counter Drug Safety, Innovation, and Reform Act; general issues related to drug pricing;issues related to cosmetic regulations; issues related to insulin pricing;issues related H.R. 6378 "Pandemic and All Hazards Preparedness (PAHPA)Advancing Innovation Act"; issues related to Medicare Part D; issues related to flu and Veterans Affairs; issues related to seasonal influenza vaccination; issues related to 340B Reform; issues related to Drug Importation; issues related to vaccine safety;issues related to HR5333 "Over-the-Counter Monograph Safety, Innovation, and reform Act of 2018; issues related to HR2212 "CREATES Act of 2017";issues related to HR 2439 "Fair Accountability and Innovation Research Drug Act of 2017"; issues related S. 2852 "Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPA) of 2018"; issues related to PAHPA reauthorization; and issues related to S.2465 "Sickle Cell Disease and other Heritable Blood Disorders Research, Surveillance, Prevention and Treatment Act of 2018"

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
MARYANNE DOLBEARE DUNLAP —
JUAN MACHADO —
KATIE OPPENHEIM —
AMY L REDL —
ELIZABETH STOWER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Natl Security Council (NSC); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB)

Bills named: H.R. 5333 (115th), S. 2465 (115th), S. 2315 (115th), S. 2852 (115th), H.R. 2439 (115th), H.R. 6378 (115th), H.R. 2212 (115th)

Budget/Appropriations BUD

Issues related to Biomedical Advanced Research and Development Authority (BARDA)" funding; and issues related to HR1892 "Bipartisan Budget Act of 2018.

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
JUAN MACHADO —
KATIE OPPENHEIM —
AMY L REDL —
ELIZABETH STOWER —

Contacted: Natl Security Council (NSC); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB)

Bills named: H.R. 1892 (115th)

Torts TOR

Issues related to Patent Reform.

Foreign entity interest: Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
MARYANNE DOLBEARE DUNLAP —
JUAN MACHADO —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Natl Security Council (NSC); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.